KONFERANS: ALAIN FISCHER – İSTANBUL

Bu etkinlik sadece İngilizcedir.

VACCINATION, STATE OF THE ART

24 Mart 2026, 18.00
Acıbadem Üniversitesi A Blok A204

Vaccination is by far the most effective medical intervention to save lives. WHO has determined that more that 150 millions lives have been spared by vaccination over the last 50 years. Advances in immunology and biotechnology have led to the development of several vaccinations platforms including mRNA to immunize safely and efficaciously against many infectious diseases. Nevetheless, population coverage is still not optimal because of persistant hesitation of a fraction of people worldwide and because vaccines are not made available equally in all parts of the word. All of these issues will be discussed during the conference.

Alain Fischer obtained his medical degree (pediatrics) in 1979. He became a professor of immunology at Paris Descartes University, and then, in 1991, became director of an INSERM unit on “Normal and Pathological Development of the Immune System.” He was head of the “Pediatric Immunology and Hematology” unit at Necker Enfants-malades Hospital (AP-HP) from 1996 to 2012. In November 2002, he was elected a member of the French Academy of Sciences and in 2011 a member of the French Academy of Medicine. He was a member of the French National Consultative Ethics Committee from 2003 to 2009. He was the founding director of the Imagine Institute for Genetic Diseases (2007-2016). Alain Fischer was elected a member of the US National Academy of Medicine in 2017 and the US National Academy of Sciences in 2019. Alain Fischer held the Chair of Experimental Medicine at the Collège de France from 2014 to 2020. His work has been recognized with numerous awards, including the Jeantet Prize (2001), the INSERM Grand Prize (2008), and the Japan Prize (2015). Alain Fischer’s work has been devoted to the study of the human immune system through the characterization of numerous genetic defects and the understanding of their pathophysiology. He successfully developed the first gene therapy trials. In 2016, he chaired the steering committee for the citizen consultation on infant vaccination and, from December 2020 to July 2022, the steering committee for the anti-Covid vaccination strategy. From January 2023 to 2025, he chaired the French Academy of Sciences.